‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker
Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs
We haven't written up this one. Financial Times has the full story — the link below goes straight to it.